T N Chase, A M Watanabe. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » AdolescentAdultAgedBlood PressureBrain/metabolismChildDihydroxyphenylalanine/therapeutic useDopamine/metabolismEvaluation Studies as TopicFemaleGastrointestinal Diseases/etiologyHeart/drug effectsHumansHydrazines/adverse effectsHydrazines/therapeutic useHydroxyindoleacetic Acid/cerebrospinal fluidMaleMethyldopa/adverse effectsMethyldopa/therapeutic useMiddle AgedMotor Skills/drug effectsParkinson Disease/drug therapyParkinson Disease/metabolismPhenylacetates/cerebrospinal fluidSerotonin/metabolism
Substances: See more » HydrazinesPhenylacetatesSerotoninHydroxyindoleacetic AcidMethyldopaDihydroxyphenylalanineDopamine
Year: 1972 PMID: 5062828 DOI: 10.1212/wnl.22.4.384
Source DB: PubMed Journal: Neurology ISSN: 0028-3878 Impact factor: 9.910